The 20 Best Hairy Cell Leukemia (HCL) Doctors Near Me in Maryland, US

Robert Kreitman is an Oncologist practicing medicine in Olney, Maryland. Dr. Kreitman is rated as an Elite provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Leukemia, Anaplastic Thyroid Cancer, and Reticuloendotheliosis.

Wyndham Wilson is an Oncologist practicing medicine in Bethesda, Maryland. Dr. Wilson is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Burkitt Lymphoma.

Dr. Lode J. Swinnen is a cancer specialist in Baltimore caring for patients with lymphoma. Dr. Swinnen received his M.B.Ch.B. degree from the University of Cape Town Medical School. He completed his residency at Presence Saint Joseph Hospital and performed a fellowship in hematology-oncology at Loyola University Stritch School of Medicine. Dr. Swinnen joined the Johns Hopkins faculty in 2002. His research interests include lymphomas and immunodeficiency-associated malignancies. Dr. Swinnen is a member of the Eastern Cooperative Oncology Group and the National Comprehensive Cancer Network. Dr. Swinnen is rated as an Advanced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Transplant. Dr. Swinnen is board certified in American Board Of Internal Medicine.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain. Dr. Lee is board certified in American Board Of Internal Medicine.

Dr. Ariel Green is Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include geriatric medicine and general internal medicine, with a particular interest in reducing use of potentially harmful medications in older adults. Dr. Green earned her medical degree, Master of Public Health and PhD in Clinical Investigation from Johns Hopkins University. She completed her residency in internal medicine at Johns Hopkins Bayview Medical Center and performed a fellowship in geriatric medicine at Johns Hopkins. Her research, supported by the National Institute on Aging, is evaluating the impact on patient and caregiver outcomes of pragmatic interventions to optimize prescribing for older adults with dementia in primary care. Dr. Green is a core faculty member of the Johns Hopkins Bloomberg School of Public Health Center for Drug Safety and Effectiveness. She is also a member of the American Geriatrics Society Clinical Practice and Models of Care Committee. She co-authored The American Geriatrics Society’s recommendations for Choosing Wisely, a national initiative that aims to promote conversations between patients and doctors about avoiding unhelpful medical tests and treatments. A former journalist, Dr. Green has published personal essays and op-eds in Annals of Internal Medicine, The Washington Post, and The New York Times, among other publications. She has been recognized with several awards, including the American Geriatrics Society Choosing Wisely Champion Award. Dr. Green is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Dementia, Microscopic Polyangiitis, Lewy Body Dementia (LBD), and Reticuloendotheliosis. Dr. Green is board certified in American Board Of Internal Medicine.

Mark Goldstein is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Goldstein is board certified in American Board Of Internal Medicine.

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia. Dr. Mener is board certified in American Board Of Internal Medicine.

As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant. Dr. Narang is board certified in American Board Of Internal Medicine.

Dr. Sterling is an oncologist who cares for patients with hematologic malignancies at the Johns Hopkins University School of Medicine. He is an active clinician with expertise in lymphoma and bone marrow transplantation and serves as the Director of the Johns Hopkins Lymphoma and Myeloma Multidisciplinary Conference. Dr. Sterling earned his undergraduate degree in biomedical sciences from Auburn University and his medical degree from Johns Hopkins University. He completed his training in internal medicine and medical oncology at Johns Hopkins before being recruited to the faculty. As a clinical investigator, Dr. Sterling's research focuses on the development of new technologies, therapies, and treatment strategies for lymphoma and other conditions treated with bone marrow transplantation. Dr. Sterling is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, T-Cell Lymphoma, and Peripheral T-Cell Lymphoma. Dr. Sterling is board certified in American Board Of Internal Medicine.

Arun Bhandari, M.D. is a native of Maryland and grew up in Silver Spring area. He earned his medical degree from Punjabi University and Government Medical College, Punjab, India and completed his internship and residency in Internal Medicine at New York University program in Queens, NY. He completed his Hematology and Oncology fellowship at University of Tennessee Health Science Center, Memphis, TN, Georgetown University and Washington Hospital Center, Washington, DC and NHLBI at National Institute of Health, Bethesda, MD. He served as a chief fellow at Georgetown University and Washington Hospital Center, Washington, D.C. After completing his fellowship in 2005, he joined as faculty at Allegheny General Hospital in Pittsburgh, PA, where he was actively involved in teaching fellows and residents. He joined COHA in 2007 at which time he opened a location in Annapolis and Kent Island. He has interest in head and neck cancer, brain cancer, breast cancer, lung cancer, gastrointestinal cancer(colon, pancreas, liver, gastric, esophageal etc.), genitourinary cancer (kidney, prostate, bladder etc.), gynecological cancer (ovarian, uterine, cervical, vaginal etc.), skin cancer, Lymphoma, Myeloma, Leukemia and various other blood disorders. He is a member of the American Society of Clinical Oncology and American Society of Hematology. He currently sees patients at Annapolis Cancer Center and Kent Island Center. He speaks English, Hindi, and Punjabi. Dr. Bhandari is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Multiple Myeloma, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia. Dr. Bhandari is board certified in American Board Of Internal Medicine.

Julie R. Brahmer, M.D., M.Sc. is the Director of the Thoracic Oncology Program, Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and the Marilyn Meyerhoff Professor in Thoracic Oncology. She also directs the Kimmel Cancer Center on the Johns Hopkins Bayview campus and is co-principal investigator on Johns Hopkins' National Clinical Trials Network. Dr. Brahmer received her undergraduate degree in Chemistry and Philosophy in 1989 from the Creighton University in Omaha, Nebraska and went on to receive her medical degree from the University of Nebraska Medical Center College of Medicine in 1993. Completing her internship and residency in Internal Medicine at the University of Utah, Dr. Brahmer later became the Chief Medical Resident until moving to Baltimore to complete her fellowship in Medical Oncology at the Kimmel Cancer Center at Johns Hopkins. Dr. Brahmer is an active clinical leader in the treatment of lung cancer and mesothelioma. She leads the organization of the multidisciplinary thoracic malignancy conference whose members meet weekly to discuss thoracic malignancy cases that need a multidisciplinary review/approach. Dr. Brahmer's research and clinical practice focuses on the development of new therapies for the treatment and prevention of lung cancer and mesothelioma. Dr. Brahmer's research interests include leading early phase immunotherapy trials of anti-PD-1 antibodies, international phase III studies of immunotherapies in lung cancer and investigator-initiated trials evaluating epigenetic therapies in combination with immunotherapies. She is a member of the American Society of Clinical Oncology and the Eastern Cooperative Oncology Group (ECOG) Thoracic Committee and Cancer Prevention Steering Committee. She is one of the founding Board members for the National Lung Cancer Partnership (formerly Women Against Lung Cancer). Within the National Lung Cancer Partnership, she currently serves as a member and the Chairman of the Scientific Executive Committee. She is also on the medical advisory board of the Lung Cancer Research Fund and the Mesothelioma Applied Research Foundation. Dr. Brahmer is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Brahmer is board certified in American Board Of Internal Medicine.

Gayatri Nimmagadda is a Hematologist and a Hematologist Oncology provider practicing medicine in Columbia, Maryland. Dr. Nimmagadda is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Pleuropulmonary Blastoma. Dr. Nimmagadda is board certified in American Board Of Internal Medicine.

Eric Christenson is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Christenson is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Pancreatic Ductal Adenocarcinoma. Dr. Christenson is board certified in American Board Of Internal Medicine.

Ravin Garg is a Hematologist Oncology specialist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Garg is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura. Dr. Garg is board certified in American Board Of Internal Medicine.

Syed Mahmood is a Hematologist and a Hematologist Oncology provider practicing medicine in Rockville, Maryland. Dr. Mahmood is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, RUNX1 Familial Platelet Disorder, Lynch Syndrome, and Colorectal Cancer. Dr. Mahmood is board certified in American Board Of Internal Medicine.

Dr. Ralph V. Boccia is a hematologist affiliated with Sibley Memorial Hospital, Suburban Hospital, Shady Grove Adventist Hospital, Holy Cross Hospital and MedStar Georgetown University Hospital, where he is a clinical associate professor of medicine for the University, as well as the medical director of the International Oncology Network (ION) Clinical Research Program and the chairman of ION’s Medical Advisory Panel. He practices out of the Center for Cancer and Blood Disorders, of which he is the founder and medical director, located in Bethesda, Maryland and Germantown, Maryland. Dr. Boccia earned his medical degree from the Autonomous University of Guadalajara School of Medicine. He completed a residency in internal medicine at Kern Medical Center, followed by a fellowship in hematology, oncology and bone marrow transplant at the combined UCLA-Veterans Administration Program and The National Cancer Institute at the National Institutes of Health. Dr. Boccia is a member of the American College of Physicians, the American Society of Clinical Oncology, the American Society of Hematology and the American Society for Blood and Marrow Transplantation. Dr. Boccia has been listed as a Top Doctor by Washingtonian Magazine and Consumers’ Checkbook Magazine since 1992. He has also been recognized as a Super Doctor by The Washington Post Magazine and a Regional Top Doctor for Washington, D.C., Baltimore and Washington-Baltimore by Castle Connolly. Dr. Boccia has contributed to various articles with his research, published in journals such as Annals of Internal Medicine, Journal of Clinical Oncology and The Lancet. Recent News Articles and Media Coverage Bladder cancer trends in Montgomery and Prince George's counties: Welcome news - and 3 facts you need to know. NJ.com (08/16/2016) RCCA Expands to Maryland to Become One of the Nation's First Multi-State Oncology/Hematology Physician-Owned and -Operated Networks. OncLive (10/06/2015). Dr. Boccia is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Anemia, Multiple Myeloma, Thrombocytopenia, Adult Immune Thrombocytopenia, and Splenectomy. Dr. Boccia is board certified in American Board Of Internal Medicine.

Stuart Selonick is an Oncologist practicing medicine in Annapolis, Maryland. Dr. Selonick is rated as an Advanced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 69 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Idiopathic Neutropenia, and Lung Cancer.

Qamar Zaman is an Oncologist practicing medicine in Cumberland, Maryland. Dr. Zaman is rated as an Advanced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 71 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Thrombocytopenia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Bone Marrow Aspiration.

Jason Taksey is an Oncologist practicing medicine in Annapolis, Maryland. Dr. Taksey is rated as an Advanced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Clear Cell Sarcoma.

Jeanine Werner is an Oncologist practicing medicine in Annapolis, Maryland. Dr. Werner is rated as an Advanced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Ovarian Carcinosarcoma.